Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems

Endocrine Reviews

Volumn 24, Issue 6, 2003, Pages 737-764

  Edmondson, Stephanie R ^a,b   Thumiger, Susan P ^a   Werther, George A ^a   Wraight, Christopher J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

BURN; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN SYNTHESIS; DERMIS; ENDOCRINE FUNCTION; EPIDERMIS HYPERPLASIA; HOMEOSTASIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIDE EFFECT; SKIN; SKIN CARCINOMA; SKIN DISEASE; SKIN INJURY; WOUND;

ANIMALS; DERMIS; EPIDERMIS; GROWTH HORMONE; HOMEOSTASIS; HUMANS; SKIN; SKIN DISEASES; SKIN PHYSIOLOGY; SOMATOMEDINS; WOUND HEALING;

EID: 0346057835     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2002-0021     Document Type: Review

References (393)

1. Nabarro JD 1987 Acromegaly. Clin Endocrinol (Oxf) 26:481-512
2. Lange M, Thulesen J, Feldt-Rasmussen U, Skakkebaek NE, Vahl N, Jorgensen JO, Christiansen JS, Poulsen SS, Sneppen SB, Juul A 2001 Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol 145:147-153
3. Wabitsch M, Hauner H, Heinze E, Teller WM 1995 The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism 44:45-49
4. Feld S, Hirschberg R 1996 Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 17:423-480
5. Su HY, Hickford JG, Bickerstaffe R, Palmer BR 1999 Insulin-like growth factor 1 and hair growth. Dermatol Online J 5:1
6. Robson H, Siebler T, Shalet SM, Williams GR 2002 Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr Res 52:137-147
7. Baserga R 1999 The IGF-I receptor in cancer research. Exp Cell Res 253:1-6
8. Baserga R 2000 The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19:5574-5581
9. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE 1995 Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 221:649-656
10. Jeschke MG, Barrow RE, Hawkins HK, Yang K, Hayes RL, Lichtenbelt BJ, Perez-Polo JR, Herndon DN 1999 IGF-I gene transfer in thermally injured rats. Gene Ther 6:1015-1020
11. Furlanetto RW, Harwell SE, Baggs RB 1993 Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice. Cancer Res 53:2522-2526
12. Wraight CJ, White PJ, McKean SC, Fogarty RD, Venables DJ, Liepe IJ, Edmondson SR, Werther GA 2000 Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nat Biotechnol 18:521-526
13. Rosenfeld RG, Roberts Jr CT 1999 The IGF system: molecular biology, physiology, and clinical applications. 1st ed. Totawa, NJ: Humana Press
14. Philpott MP, Sanders D, Westgate GE, Kealey T 1994 Human hair growth in vitro: a model for the study of hair follicle biology. J Dermatol Sci 7(Suppl):S55-S72
15. Peus D, Pittelkow MR 1996 Growth factors in hair organ development and the hair growth cycle. Dermatol Clin 14:559-572
16. Deplewski D, Rosenfield RL 2000 Role of hormones in pilosebaceous unit development. Endocr Rev 21:363-392
17. Daughaday WH, Salmon Jr WD 1999 The origins and development of the somatomedin hypothesis. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 1-18
18. Daughaday WH 1972 Somatomedin: proposed designation for sulphation factor. Nature 235:107
19. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
20. Barnard R, Bundesen PG, Rylatt DB, Waters MJ 1984 Monoclonal antibodies to the rabbit liver growth hormone receptor: production and characterization. Endocrinology 115:1805-1813
21. Werther GA, Haynes K, Waters MJ 1993 Growth hormone (GH) receptors are expressed on human fetal mesenchymal tissues-identification of messenger ribonucleic acid and GH-binding protein. J Clin Endocrinol Metab 76:1638-1646
22. Edmondson SR, Werther GA, Russell A, Le Roith D, Roberts Jr CT, Beck F 1995 Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: relationship to insulin-like growth factor-I mRNA. Endocrinology 136:4602-4609
23. Pantaleon M, Whiteside EJ, Harvey MB, Barnard RT, Waters MJ, Kaye PL 1997 Functional growth hormone (GH) receptors and GH are expressed by preimplantation mouse embryos: a role for GH in early embryogenesis? Proc Natl Acad Sci USA 94:5125-5130
24. Weigent DA, Blalock JE 1991 The production of growth hormone by subpopulations of rat mononuclear leukocytes. Cell Immunol 135:55-65
25. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ 1993 Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res Dev Brain Res 74:225-233
26. Harvey S, Johnson CD, Sharma P, Sanders EJ, Hull KL 1998 Growth hormone: a paracrine growth factor in embryonic development? Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 119:305-315
27. Zezulak KM, Green H 1986 The generation of insulin-like growth factor-1: sensitive cells by growth hormone action. Science 233:551-553
28. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, Duursma SA 1988 Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinol (Copenh) 118:294-300
29. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19:55-79
30. Yakar S, Liu JL, Le Roith D 2000 The growth hormone/insulin-like growth factor-I system: implications for organ growth and development. Pediatr Nephrol 14:544-549
31. Butler AA, LeRoith D 2001 Minireview: tissue-specific vs. generalized gene targeting of the IGF1 and IGF1R genes and their roles in insulin-like growth factor physiology. Endocrinology 142:1685-1688
32. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781
33. Jansson JO, Eden S, Isaksson O 1985 Sexual dimorphism in the control of growth hormone secretion. Endocr Rev 6:128-150
34. Bertherat J, Bluet-Pajot MT, Epelbaum J 1995 Neuroendocrine regulation of growth hormone. Eur J Endocrinol 132:12-24
35. Casanueva FF, Dieguez C 1998 Interaction between body composition, leptin and growth hormone status. Baillieres Clin Endocrinol Metab 12:297-314
36. Wang G, Lee HM, Englander E, Greeley Jr GH 2002 Ghrelin-not just another stomach hormone. Regul Pept 105:75-81
37. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K 2000 Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
38. Pekhletsky RI, Chernov BK, Rubtsov PM 1992 Variants of the 5′-untranslated sequence of human growth hormone receptor mRNA. Mol Cell Endocrinol 90:103-109
39. Dastot F, Sobrier ML, Duquesnoy P, Duriez B, Goossens M, Amselem S 1996 Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein. Proc Natl Acad Sci USA 93:10723-10728
40. Ross RJ, Esposito N, Shen XY, Von Laue S, Chew SL, Dobson PR, Postel-Vinay MC, Finidori J 1997 A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 11:265-273
41. Edens A, Talamantes F 1998 Alternative processing of growth hormone receptor transcripts. Endocr Rev 19:559-582
42. Fisker S, Kristensen K, Rosenfalck AM, Pedersen SB, Ebdrup L, Richelsen B, Hilsted J, Christiansen JS, Jorgensen JO 2001 Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. J Clin Endocrinol Metab 86:792-796
43. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J 1993 Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 132:1863-1865
44. Lim L, Spencer SA, McKay P, Waters MJ 1990 Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology 127:1287-1291
45. Baumann G 1991 Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 12:424-449
46. Alele J, Jiang J, Goldsmith JF, Yang X, Maheshwari HG, Black RA, Baumann G, Frank SJ 1998 Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. Endocrinology 139:1927-1935
47. Cunningham BC, Ultsch M, de Vos AM, Mulkerrin MG, Clauser KR, Wells JA 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
48. de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
49. Frank SJ 2001 Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm IGF Res 11:201-212
50. Herrington J, Carter-Su C 2001 Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 12:252-257
51. Argetsinger LS, Hsu GW, Myers Jr MG, Billestrup N, White MF, Carter-Su C 1995 Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 270:14685-14692
52. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C 1996 Growth hormone, interferon-γ, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 271:29415-29421
53. Ridderstrale M, Tornqvist H 1996 Effects of tyrosine kinase inhibitors on tyrosine phosphorylations and the insulin-like effects in response to human growth hormone in isolated rat adipocytes. Endocrinology 137:4650-4656
54. Nilsson A, Ohlsson C, Isaksson OG, Lindahl A, Isgaard J 1994 Hormonal regulation of longitudinal bone growth. Eur J Clin Nutr 48(Suppl 1):S150-S158
55. Cook JJ, Haynes KM, Werther GA 1988 Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production. J Clin Invest 81:206-212
56. Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G, Mehls O 1998 Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH-and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139:3296-3305
57. Tavakkol A, Elder JT, Griffiths CE, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, Voorhees JJ 1992 Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 99:343-349
58. Herington AC, Stevenson JL, Andrew I 1985 Demonstration of in vitro actions of growth hormone on isolated rat adipocytes. Horm Metab Res 17:16-19
59. Isaksson OG, Lindahl A, Nilsson A, Isgaard J 1987 Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438
60. Lindahl A, Isgaard J, Isaksson OG 1987 Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats. Endocrinology 121:1070-1075
61. Waters M, Thompson B 1999 Growth hormone: new insights into a multi-talented hormone. Today's Life Science (Nov/Dec) 32-38
62. Carter-Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
63. Eriksson H, Ridderstrale M, Tornqvist H 1995 Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. Endocrinology 136:5093-5101
64. Kopchick JJ, Bellush LL, Coschigano KT 1999 Transgenic models of growth hormone action. Annu Rev Nutr 19:437-461
65. Melmed S 1990 Acromegaly. N Engl J Med 322:966-977
66. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J 1994 Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390
67. Maheshwari HG, Silverman BL, Dupuis J, Baumann G 1998 Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J Clin Endocrinol Metab 83:4065-4074
68. Rajaram S, Baylink DJ, Mohan S 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18:801-831
69. Price GJ, Berka JL, Edmondson SR, Werther GA, Bach LA 1995 Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney. Kidney Int 48:402-411
70. Batch JA, Mercuri FA, Werther GA 1996 Identification and localization of insulin-like growth factor-binding protein (IGFBP) messenger RNAs in human hair follicle dermal papilla. J Invest Dermatol 106:471-475
71. Burren CP, Berka JA, Edmondson SR, Werther GA, Batch JA 1996 Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor and IGF binding proteins in rat eye. Invest Ophthalmol Vis Sci 37:1459-1468
72. Werther GA, Russo V, Baker N, Butler G 1998 The role of the insulin-like growth factor system in the developing brain. Horm Res 49(Suppl 1):37-40
73. Dean R, Edmondson SR, Burrell LM, Bach LA 1999 Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction. J Histochem Cytochem 47:649-660
74. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
75. Collett-Solberg PF, Cohen P 2000 Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 12:121-136
76. Adams TE, Epa VC, Garrett TP, Ward CW 2000 Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093
77. Salmon WDJ, Daughaday W 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836
78. Rinderknecht E, Humbel RE 1976 Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Proc Natl Acad Sci USA 73:2365-2369
79. Rinderknecht E, Humbel RE 1978 The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769-2776
80. Rinderknecht E, Humbel RE 1978 Primary structure of human insulin-like growth factor II. FEBS Lett 89:283-286
81. Klapper DG, Svoboda ME, Van Wyk JJ 1983 Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I. Endocrinology 112:2215-2217
82. Rotwein P 1999 Molecular biology of IGF-I and IGF-II. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications, 17th ed. Totowa, NJ: Humana Press; 19-36
83. Holthuizen PE, Steenbergh PH, Sussenbach JS 1999 Regulation of IGF gene expression. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 37-62
84. Hynes MA, Van Wyk JJ, Brooks PJ, D'Ercole AJ, Jansen M, Lund PK 1987 Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids. Mol Endocrinol 1:233-242
85. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
86. Schumacher R, Mosthaf L, Schlessinger J, Brandenburg D, Ullrich A 1991 Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem 266:19288-19295
87. Kjeldsen T, Andersen AS, Wiberg FC, Rasmussen JS, Schaffer L, Balschmidt P, Moller KB, Moller NP 1991 The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Proc Natl Acad Sci USA 88:4404-4408
88. Zhang B, Roth RA 1991 Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Biochemistry 30:5113-5117
89. Werner H 1999 Molecular biology of the type 1 IGF receptor. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 63-88
90. Braulke T 1999 Type-2 IGF receptor: a multi-ligand binding protein. Horm Metab Res 31:242-246
91. Forbes BE, Hartfield PJ, McNeil KA, Surinya KH, Milner SJ, Cosgrove LJ, Wallace JC 2002 Characteristics of binding of insulin-like growth factor (IGF) -I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur J Biochem 269:961-968
92. Blakesley VA, Scrimgeour A, Esposito D, Le Roith D 1996 Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? Cytokine Growth Factor Rev 7:153-159
93. Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D 1998 Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp Biochem Physiol B Biochem Mol Biol 121:19-26
94. Sepp-Lorenzino L 1998 Structure and function of the insulin-like growth factor I receptor. Breast Cancer Res Treat 47:235-253
95. Petley T, Graff K, Jiang W, Yang H, Florini J 1999 Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 31:70-76
96. Blakesley VA, Butler AA, Koval AP, Okubo Y, LeRoith D 1999 IGF-I receptor function: transducing the IGF-I signal into intracellular events. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 143-164
97. Esposito DL, Blakesley VA, Koval AP, Scrimgeour AG, LeRoith D 1997 Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Endocrinology 138:2979-2988
98. Dupont J, LeRoith D 2001 Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res 55(Suppl 2):22-26
99. Keiss W 1999 Molecular biology of the IGF-II/mannose-6-phosphate receptor. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 89-110
100. Clairmont KB, Czech MP 1991 Extracellular release as the major degradative pathway of the insulin-like growth factor II/mannose 6-phosphate receptor. J Biol Chem 266:12131-12134
101. Bobek G, Scott CD, Baxter RC 1992 Radioimmunoassay of soluble insulin-like growth factor-II/mannose 6-phosphate receptor: developmental regulation of receptor release by rat tissues in culture. Endocrinology 130:3387-3394
102. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
103. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (Igf1r). Cell 75:59-72
104. Wood TL 1995 Gene-targeting and transgenic approaches to IGF and IGF binding protein function. Am J Physiol 269:E613-E622
105. D'Ercole AJ 1999 Actions of IGF system proteins from studies of transgenic and gene knockout models. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 545-574
106. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
107. Liu JL, LeRoith D 1999 Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140:5178-5184
108. Ohlsson C, Sjogren K, Jansson JO, Isaksson OG 2000 The relative importance of endocrine vs. autocrine/paracrine insulin-like growth factor-I in the regulation of body growth. Pediatr Nephrol 14:541-543
109. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ 1979 Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279-1283
110. Campisi J, Pardee AB 1984 Post-transcriptional control of the onset of DNA synthesis by an insulin-like growth factor. Mol Cell Biol 4:1807-1814
111. Adesanya OO, Zhou J, Samathanam C, Powell-Braxton L, Bondy CA 1999 Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc Natl Acad Sci USA 96:3287-3291
112. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R 1995 Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55:3739-3741
113. D'Ambrosio C, Ferber A, Resnicoff M, Baserga R 1996 A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res 56:4013-4020
114. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R 1995 The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55:2463-2469
115. D'Ambrosio C, Valentinis B, Prisco M, Reiss K, Rubini M, Baserga R 1997 Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid. Cancer Res 57:3264-3271
116. Dews M, Nishimoto I, Baserga R 1997 IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Recept Signal Transduct 7:231-240
117. Prisco M, Hongo A, Rizzo MG, Sacchi A, Baserga R 1997 The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol 17:1084-1092
118. Kanter-Lewensohn L, Dricu A, Girnita L, Wejde J, Larsson O 2000 Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins. Growth Factors 17:193-202
119. Tsuboi R, Sato C, Shi CM, Ogawa H 1992 Stimulation of keratinocyte migration by growth factors. J Dermatol 19:652-653
120. Ando Y, Jensen PJ 1993 Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J Invest Dermatol 100:633-639
121. Zeigler ME, Krause S, Karmiol S, Varani J 1996 Growth factor-induced epidermal invasion of the dermis in human skin organ culture: dermal invasion correlated with epithelial cell motility. Invasion Metastasis 16:3-10
122. Andresen JL, Ledet T, Ehlers N 1997 Keratocyte migration and peptide growth factors: the effect of PDGF, bFGF, EGF, IGF-I, aFGF and TGF-β on human keratocyte migration in a collagen gel. Curr Eye Res 16:605-613
123. Andresen JL, Ehlers N 1998 Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-α, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-β. Curr Eye Res 17:79-87
124. Ghahary A, Shen YJ, Nedelec B, Scott PG, Tredget EE 1995 Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 148:25-32
125. Telasky C, Tredget EE, Shen Q, Khorramizadeh MR, Iwashina T, Scott PG, Ghahary A 1998 IFN-α2b suppresses the fibrogenic effects of insulin-like growth factor-1 in dermal fibroblasts. J Interferon Cytokine Res 18:571-577
126. Dimitriadis G, Parry-Billings M, Bevan S, Dunger D, Piva T, Krause U, Wegener G, Newsholme EA 1992 Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J 285:269-274
127. Firth SM, McDougall F, McLachlan AJ, Baxter RC 2002 Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex-forming ability. Endocrinology 143:1669-1676
128. Zapf J, Waldvogel M, Froesch ER 1975 Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys 168:638-645
129. Baxter RC 2000 Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967-E976
130. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144
131. Boisclair YR, Rhoads RP, Ueki I, Wang J, Ooi GT 2001 The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 170:63-70
132. Martin JL, Baxter RC 1999 IGF binding protein as modulators of IGF action. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. 17th ed. Totowa, NJ: Humana Press; 227-255
133. DeMellow JSM, Baxter RC 1988 Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochem Biophys Res Comm 156:199-204
134. Conover CA 1992 Potentiation of insulin-like growth factor (IGF) action by IGF binding protein-3: studies of underlying mechanism. Endocrinology 130:3191-3199
135. Mohan S, Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31
136. Clemmons DR 2001 Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr Rev 22:800-817
137. Maile LA, Holly JM 1999 Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 9:85-95
138. Rajah R, Lee KW, Cohen P 2002 Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-α-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ 13:163-171
139. Oh Y, Müller HL, Ng L, Rosenfeld RG 1995 Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 270:13589-13592
140. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
141. Butt AJ, Firth SM, Baxter RC 1999 The IGF axis and programmed cell death. Immunol Cell Biol 77:256-262
142. Hollowood AD, Lai T, Perks CM, Newcomb PV, Alderson D, Holly JM 2000 IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer 88:336-341
143. Grimberg A, Liu B, Bannerman P, El-Deiry WS, Cohen P 2002 IGFBP-3 mediates p53-induced apoptosis during serum starvation. Int J Oncol 21:327-335
144. Rajah R, Valentinis B, Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272:12181-12188
145. Schedlich LJ, Graham LD 2002 Role of insulin-like growth factor binding protein-3 in breast cancer cell growth. Microsc Res Tech 59:12-22
146. 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-10557
147. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
148. Lalou C, Lassarre C, Binoux M 1996 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137:3206-3212
149. Zadeh SM, Binoux M 1997 The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138:3069-3072
150. Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y 1997 Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem 272:30729-30734
151. Vorwerk P, Yamanaka Y, Spagnoli A, Oh Y, Rosenfeld RG 1998 Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J Clin Endocrinol Metab 83:1392-1395
152. Oh Y, Muller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048
153. Leal SM, Liu Q, Huang SS, Huang JS 1997 The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 272:20572-20576
154. Leal SM, Huang SS, Huang JS 1999 Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J Biol Chem 274:6711-6717
155. Fanayan S, Firth SM, Baxter RC 2002 Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-β 1 signaling. J Biol Chem 277:7255-7261
156. Radulescu RT 1994 Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem Sci 19:278
157. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K 1997 Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138:1767-1770
158. Li W, Fawcett J, Widmer HR, Fielder PJ, Rabkin R, Keller GA 1997 Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 138:1763-1766
159. Wraight CJ, Liepe IJ, White PJ, Hibbs AR, Werther GA 1998 Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J Invest Dermatol 111:239-242
160. Schedlich LJ, Young TF, Firth SM, Baxter RC 1998 Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273:18347-18352
161. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P 2000 Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613
162. Mannhardt B, Weinzimer SA, Wagner M, Fiedler M, Cohen P, Jansen-Durr P, Zwerschke W 2000 Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol 20:6483-6495
163. Zatsepina O, Braspenning J, Robberson D, Hajibagheri MA, Blight KJ, Ely S, Hibma M, Spitkovsky D, Trendelenburg M, Crawford L, Tommasino M 1997 The human papillomavirus type 16 E7 protein is associated with the nucleolus in mammalian and yeast cells. Oncogene 14:1137-1145
164. Schaefer H, Redelmeier TE 1996 Structure and dynamics of the skin barrier. In: Skin barrier: principles of percutaneous absorption. Basel, Switzerland: Karger; 1-42
165. Seiberg M 2001 Keratinocyte-melanocyte interactions during melanosome transfer. Pigment Cell Res 14:236-242
166. Yaar M, Gilchrest BA 1991 Human melanocyte growth and differentiation: a decade of new data. J Invest Dermatol 97:611-617
167. Gordon PR, Mansur CP, Gilchrest BA 1989 Regulation of human melanocyte growth, dendricitiy, and melanization by keratinocyte derived factors. J Invest Dermatol 92:565-572
168. Scott GA, Haake AR 1991 Keratinocytes regulate melanocyte number in human fetal and neonatal skin equivalents. J Invest Dermatol 97:776-781
169. Fine JD 2000 Basement membrane proteins. In: Leigh IM, Birgitte Lane E, Watt FM, eds. The keratinocyte handbook. Cambridge, UK: Cambridge University Press; 181-199
170. Watt FM 1998 Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci 353:831-837
171. Ortonne JP 1996 Aetiology and pathogenesis of psoriasis. Br J Dermatol 135(Suppl 49):1-5
172. Eckert RL, Crish JF, Robinson NA 1997 The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397-424
173. Fuchs E, Byrne C 1994 The epidermis: rising to the surface. Curr Opin Genet Dev 4:725-736
174. Piepkorn M, Pittelkow MR, Cook PW 1998 Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 111:715-721
175. Letterio JJ, Bottinger EP 1998 TGF-β knockout and dominant-negative receptor transgenic mice. Miner Electrolyte Metab 24:161-167
176. Bikle DD 1997 Vitamin D: a calciotropic hormone regulating calcium-induced keratinocyte differentiation. J Am Acad Dermatol 37:S42-S52
177. Fisher GJ, Voorhees JJ 1996 Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013
178. Cotsarelis G, Kaur P, Dhouailly D, Hengge U, Bickenbach J 1999 Epithelial stem cells in the skin: definition, markers, localization and functions. Exp Dermatol 8:80-88
179. Levy L, Broad S, Diekmann D, Evans RD, Watt FM 2000 β1 Integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol Biol Cell 11:453-466
180. Menon GK, Grayson S, Elias PM 1985 Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 84:508-512
181. + gradients in murine epidermis: quantitative measurement using PIXE. J Invest Dermatol 111:1198-1201
182. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z 2001 Calcium-and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 177:161-171
183. Dykes PJ, Jenner LA, Marks R 1982 The effect of calcium on the initiation and growth of human epidermal cells. Arch Dermatol Res 273:225-231
184. Boyce ST, Ham RG 1983 Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 81(Suppl):33s-40s
185. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH 1980 Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254
186. Gibson DF, Ratnam AV, Bikle DD 1996 Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J Invest Dermatol 106:154-161
187. Lavker RM, Sun TT 1982 Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations. Science 215:1239-1241
188. Potten CS, Morris RJ 1988 Epithelial stem cells in vivo. J Cell Sci Suppl 10:45-62
189. Kaur P, Li A 2000 Adhesive properties of human basal epidermal cells: an analysis of keratinocyte stem cells, transit amplifying cells, and postmitotic differentiating cells. J Invest Dermatol 114:413-420
190. Janes SM, Lowell S, Hutter C 2002 Epidermal stem cells. J Pathol 197:479-491
191. Potten CS, Booth C 2002 Keratinocyte stem cells: a commentary. J Invest Dermatol 119:888-899
192. Barrandon Y, Green H 1987 Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84:2302-2306
193. Jensen UB, Lowell S, Watt FM 1999 The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development 126:2409-2418
194. Lobie PE, Garcia-Aragon J, Wang BS, Baumbach WR, Waters MJ 1992 Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130:3057-3065
195. Lincoln DT, Sinowatz F, Temmim-Baker L, Baker HI, Kolle S, Waters MJ 1998 Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol 109:141-159
196. Hill DJ, Riley SC, Bassett NS, Waters MJ 1992 Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. J Clin Endocrinol Metab 75:646-650
197. Mertani HC, Morel G 1995 In situ gene expression of growth hormone (GH) receptor and GH binding protein in adult male rat tissues. Mol Cell Endocrinol 109:47-61
198. Zogopoulos G, Figueiredo R, Jenab A, Ali Z, Lefebvre Y, Goodyer CG 1996 Expression of exon 3-retaining and -deleted human growth hormone receptor messenger ribonucleic acid isoforms during development. J Clin Endocrinol Metab 81:775-782
199. Oakes SR, Haynes KM, Waters MJ, Herington AC, Werther GA 1992 Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab 75:1368-1373
200. Freeth JS, Ayling RM, Whatmore AJ, Towner P, Price DA, Norman MR, Clayton PE 1997 Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome. Endocrinology 138:55-61
201. Palmetshofer A, Zechner D, Luger TA, Barta A 1995 Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts. Mol Cell Endocrinol 113:225-234
202. Thorner MO, Vance ML, Horvath E, Kovacs K 1992 The anterior pituitary. In: Wilson JD, Fodter DW, eds. Textbook of endocrinology. Philadelphia: W. B. Saunders; 234
203. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
204. Conte F, Diridollou S, Jouret B, Turlier V, Charveron M, Gall Y, Rochiccioli P, Bieth E, Tauber M 2000 Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient children. Horm Res 54:92-97
205. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1-6
206. Lonn L, Johansson G, Sjostrom L, Kvist H, Oden A, Bengtsson BA 1996 Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment. Obes Res 4:45-54
207. Blok GJ, de Boer H, Gooren LJ, van der Veen EA 1997 Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin Endocrinol (Oxf) 47:29-36
208. Wanke R, Milz S, Rieger N, Ogiolda L, Renner-Muller I, Brem G, Hermanns W, Wolf E 1999 Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. J Invest Dermatol 113:967-971
209. Jorgensen PH, Andreassen TT, Jorgensen KD 1989 Growth hormone influences collagen deposition and mechanical strength of intact rat skin. A dose-response study. Acta Endocrinol (Copenh) 120:767-772
210. Prahalada S, Stabinski LG, Chen HY, Morrissey RE, De Burlet G, Holder D, Patrick DH, Peter CP, van Zwieten MJ 1998 Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs. Toxicol Pathol 26:185-200
211. Murphy LJ, Vrhovsek E, Lazarus L 1983 Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. J Clin Endocrinol Metab 57:1117-1124
212. Freeth JS, Silva CM, Whatmore AJ, Clayton PE 1998 Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children. Endocrinology 139:20-28
213. Barreca A, Larizza D, Damonte G, Arvigo M, Ponzani P, Cesarone A, Lo Curto F, Severi F, Giordano G, Minuto F 1997 Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture. J Clin Endocrinol Metab 82:1041-1046
214. Granot I, Halevy O, Hurwitz S, Pines M 1991 Growth hormone and insulin-like growth factor I regulate collagen gene expression and extracellular collagen in cultures of avian skin fibroblasts. Mol Cell Endocrinol 80:1-9
215. Tavakkol A, Varani J, Elder JT, Zouboulis CC 1999 Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch Dermatol Res 291:643-651
216. Rudman SM, Philpott MP, Thomas GA, Kealey T 1997 The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol 109:770-777
217. Nissley SP, Rechler MM 1984 Somatomedin/insulin-like growth factor tissue receptors. Clin Endocrinol Metab 13:43-67
218. Thorsson AV, Hintz RL, Enberg G, Hall K 1985 Characterization of insulin-like growth factor II binding to human fibroblast monolayer cultures. J Clin Endocrinol Metab 60:387-391
219. Conover CA, Hintz RL, Rosenfeld RG 1987 Impaired synergism between somatomedin C/insulin-like growth factor I and dexamethasone in the growth of fibroblasts from a patient with insulin resistance. Pediatric Res 22:188-191
220. Desnoyers L, Simonette RA, Vandlen RL, Fendly BM 2001 Novel non-isotopic method for the localization of receptors in tissue sections. J Histochem Cytochem 49:1509-1518
221. Batch JA, Mercuri FA, Edmondson SR, Werther GA 1994 Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 79:1444-1449
222. Martin JL, Baxter RC 1988 Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs. Endocrinology 123:1907-1915
223. Arai T, Arai A, Busby Jr WH, Clemmons DR 1994 Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology 135:2358-2363
224. Martin JL, Coverley JA, Baxter RC 1994 Regulation of immunoreactive insulin-like growth factor binding protein-6 in normal and transformed human fibroblasts. J Biol Chem 269:11470-11477
225. Xu S, Cwyfan-Hughes SC, van der Stappen JW, Sansom J, Burton JL, Donnelly M, Holly JM 1995 Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. J Clin Endocrinol Metab 80:2940-2945
226. Xu S, Cwyfan-Hughes SC, van der Stappen JW, Sansom J, Burton JL, Donnelly M, Holly JM 1996 Altered insulin-like growth factor-II (IGF-II) level and IGF-binding protein-3 (IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J Invest Dermatol 106:109-112
227. Xu S, Savage P, Burton JL, Sansom J, Holly JM 1997 Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: the role and regulation of components of the plasmin system. J Clin Endocrinol Metab 82:1863-1868
228. Conover CA, Durham SK, Zapf J, Masiarz FR, Kiefer MC 1995 Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 270:4395-4400
229. Martin JL, Baxter RC 1990 Production of an insulin-like growth factor (IGF-) inducible IGF-binding protein by human skin fibroblasts. Endocrinology 127:781-788
230. Yoshizawa A, Clemmons DR 2000 Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab 85:1627-1633
231. Conover CA, Clarkson JT, Bale LK 1995 Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology 136:1403-1410
232. Sell C, Ptasznik A, Chang CD, Swantek J, Cristofalo VJ, Baserga R 1993 IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts. Biochem Biophys Res Commun 194:259-265
233. Ferber A, Chang C, Sell C, Ptasznik A, Cristofalo VJ, Hubbard K, Ozer HL, Adamo M, Roberts Jr CT, LeRoith D 1993 Failure of senescent human fibroblasts to express the insulin-like growth factor-1 gene. J Biol Chem 268:17883-17888
234. Moerman EJ, Thweatt R, Moerman AM, Jones RA, Goldstein S 1993 Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts. Exp Gerontol 28:361-370
235. Goldstein S, Moerman EJ, Jones RA, Baxter RC 1991 Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc Natl Acad Sci USA 88:9680-9684
236. Goldstein S, Moerman EJ, Baxter RC 1993 Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro. J Cell Physiol 156:294-302
237. Grigoriev VG, Moerman EJ, Goldstein S 1995 Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: attenuation of the mitogenic response to IGF-I. Exp Cell Res 219:315-321
238. Conover CA, Rosenfeld RG, Hintz RL 1986 Hormonal control of the replication of human fetal fibroblasts: role of somatomedin C/insulin-like growth factor I. J Cell Physiol 128:47-54
239. Tamm I, Kikuchi T 1991 Activation of signal transduction path ways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivation. J Cell Physiol 148:85-95
240. Yoshimoto H, Ishihara H, Ohtsuru A, Akino K, Murakami R, Kuroda H, Namba H, Ito M, Fujii T, Yamashita S 1999 Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 154:883-889
241. Ghahary A, Shen Q, Shen YJ, Scott PG, Tredget EE 1998 Induction of transforming growth factor β 1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 174:301-309
242. Gillery P, Leperre A, Maquart FX, Borel JP 1992 Insulin-like growth factor-I (IGF-I) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J Cell Physiol 152:389-396
243. Ghahary A, Tredget EE, Mi L, Yang L 1999 Cellular response to latent TGF-β1 is facilitated by insulin-like growth factor-II/ mannose-6-phosphate receptors on MS-9 cells. Exp Cell Res 251:111-120
244. Glick AB, Danielpour D, Morgan D, Sporn MB, Yuspa SH 1990 Induction and autocrine receptor binding of transforming growth factor-β 2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol 4:46-52
245. Kato M, Ishizaki A, Hellman U, Wernstedt C, Kyogoleu M, Miyazono K, Heldon CH, Funa K 1995 A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium and cell density-dependent manner. J Biol Chem 270:12373-12379
246. Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC 1990 Transforming growth factor-β 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 144:144-150
247. Kratz G, Haegerstrand A, Dalsgaard CJ 1991 Conditioned medium from cultured human keratinocytes has growth stimulatory properties on different human cell types. J Invest Dermatol 97:1039-1043
248. Conover CA, Bale LK, Durham SK, Powell DR 2000 Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Endocrinology 141:3098-3103
249. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
250. Jones JI, Gockerman A, Busby Jr WH, Camacho-Hubner C, Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121:679-687
251. Fowlkes JL 1997 Insulin-like growth factor-binding protein proteolysis: an emerging paradigm in insulin-like growth factor physiology. Trends Endocrinol Metab 8:299-306
252. Nam TJ, Busby Jr WH, Clemmons DR 1996 Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. Endocrinology 137:5530-5536
253. Conover CA, Kiefer MC, Zapf J 1993 Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts: insulin-like growth factor dependence and biological studies. J Clin Invest 91:1129-1137
254. Conover CA, De Leon DD 1994 Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 269:7076-7080
255. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates 3rd JR, Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153
256. Fowlkes JL, Serra DM, Rosenberg CK, Thrailkill KM 1995 Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem 270:27481-27488
257. Lalou C, Lassarre C, Binoux M 1995 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGF is a cell growth inhibitor. Prog Growth Factor Res 6:311-316
258. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367
259. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ 1990 Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 126:467-471
260. Simard M, Manthos H, Giaid A, Lefebvre Y, Goodyer CG 1996 Ontogeny of growth hormone receptors in human tissues: an immunohistochemical study. J Clin Endocrinol Metab 81:3097-3102
261. Gilhar A, Ish-Shalom S, Pillar T, Etzioni A, Silbermann M 1994 Effect of antiinsulin-like growth factor 1 on epidermal proliferation of human skin transplanted onto nude mice treated with growth hormone. Endocrinology 134:229-232
262. Edmondson SR, Russo VC, McFarlane AC, Wraight CJ, Werther GA 1999 Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth. J Clin Endocrinol Metab 84:1638-1644
263. Kodak E, Gottlieb AB, Anzilotti M, Krueger JG 1996 The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J Invest Dermatol 106:564-570
264. Edmondson SR, Werther GA, Wraight CJ 2001 Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT. J Invest Dermatol 116:491-497
265. Wertheimer E, Trebicz M, Eldar T, Gartsbein M, Nofeh-Moses S, Tennenbaum T 2000 Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. J Invest Dermatol 115:24-29
266. Barreca A, DeLuca M, Del Monte P, Bondanza S, Damonte G, Cariola G, DiMarco E, Giordano G, Cancedda R, Minuto F 1992 In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 151:262-268
267. Rheinwald JG, Green H 1975 Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-343
268. Marinaro JA, Hendrich EC, Leeding KS, Bach LA 1999 HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6. Am J Physiol 276:E536-E542
269. Swope VB, Supp AP, Greenhalgh DG, Warden GD, Boyce ST 2001 Expression of insulin-like growth factor I by cultured skin substitutes does not replace the physiologic requirement for insulin in vitro. J Invest Dermatol 116:650-657
270. Gartner MH, Benson JD, Caldwell MD 1992 Insulin-like growth factors I and II expression in the healing wound. J Surg Res 52:389-394
271. Brown DL, Kane CD, Chernausek SD, Greenhalgh DG 1997 Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 151:715-724
272. Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW 2000 Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 589-594
273. Braulke T, Gotz W, Claussen M 1996 Immunohistochemical localization of insulin-like growth factor binding protein-1, -3 and -4 in human fetal tissues and their analysis in media from fetal tissue explants. Growth Regul 6:55-65
274. Rho O, Bol DK, You J, Beltran L, Rupp T, DiGiovanni J 1996 Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin. Mol Carcinog 17:62-69
275. Murashita MM, Russo VC, Edmondson SR, Wraight CJ, Werther GA 1995 Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes. J Cell Physiol 163:339-345
276. Wraight CJ, Murashita MM, Russo VC, Werther GA 1994 A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action. J Invest Dermatol 103:627-631
277. Wraight CJ, Edmondson SR, Fortune DW, Varigos G, Werther GA 1997 Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion. J Invest Dermatol 108:452-456
278. Delhanty PJ, Hill DJ, Shimasaki S, Han VK 1993 Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation? Growth Regul 3:8-11
279. Wraight CJ, Werther GA 1995 Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J Invest Dermatol 105:602-607
280. Edmondson SR, Murashita MM, Russo VC, Wraight CJ, Werther GA 1999 Expression of insulin-like growth factor binding protein-3 (IGFBP-3) inhuman keratinocytes is regulated by EGF and TGFβ1. J Cell Physiol 179:201-207
281. Boukamp P, Popp S, Altmeyer S, Hulsen A, Fasching C, Cremer T, Fusenig NE 1997 Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes Cancer 19:201-214
282. Hughes SC, Xu S, Fernihough J, Hampton A, Mason HD, Franks S, van der Stappen J, Donnelly MJ, Holly JM 1995 Tissue IGFBP-3 proteolysis: contrasting pathophysiology to that in the circulation. Prog Growth Factor Res 6:293-299
283. Herlyn M, Mancianti ML, Jambrosic J, Bolen JB, Koprowski H 1988 Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp Cell Res 179:322-331
284. Zendegui JG, Inman WH, Carpenter G 1988 Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-β. J Cell Physiol 136:257-265
285. Neely EK, Morhenn VB, Hintz RH, Wilson DM, Rosenfeld RG 1991 Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol 96:104-110
286. Wertheimer E, Spravchikov N, Trebicz M, Gartsbein M, Accili D, Avinoah I, Nofeh-Moses S, Sizyakov G, Tennenbaum T 2001 The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 142:1234-1241
287. Shen S, Alt A, Wertheimer E, Gartsbein M, Kuroki T, Ohba M, Braiman L, Sampson SR, Tennenbaum T 2001 PKC δ activation: a divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes. Diabetes 50:255-264
288. DeLapp NW, Dieckman DK 1990 Effect of basic fibroblast growth factor (bFGF) and insulin-like growth factors type I (IGF-I) and type II (IGF-II) on adult human keratinocyte growth and fibronectin secretion. J Invest Dermatol 94:777-780
289. Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E 2001 Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes 50:1627-1635
290. Ristow HJ, Messmer TO 1988 Basic fibroblast growth factor and insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J Cell Physiol 137:277-284
291. O'Keefe EJ, Chiu ML 1988 Stimulation of thymidine incorporation in keratinocytes by insulin, epidermal growth factor and placental extract: comparison with cell number to assess growth. J Invest Dermatol 90:2-7
292. Cook PW, Pittelkow MR, Shipley GD 1991 Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine-and paracrine-acting mitogenic factors. J Cell Physiol 146:277-289
293. Krane JF, Murphy DP, Carter DM, Krueger JG 1991 Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 96:419-424
294. Vardy DA, Kari C, Lazarus GS, Jensen PJ, Zilberstein A, Plowman GD, Rodeck U 1995 Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1. J Cell Physiol 163:257-265
295. Marikovsky M, Vogt P, Eriksson E, Rubin JS, Taylor WG, Joachim S, Klagsbrun M 1996 Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J Invest Dermatol 106:616-621
296. Ristow HJ 1996 Studies on stimulation of DNA synthesis with epidermal growth factor and insulin-like growth factor-I in cultured human keratinocytes. Growth Regul 6:96-109
297. Krane JF, Gottlieb AB, Carter DM, Krueger JG 1992 The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J Exp Med 175:1081-1090
298. Kamalati T, Howard M, Brooks RF 1989 IGF-I induces differentiation in a transformed human keratinocyte line. Development 106:283-293
299. Tron VA, Trotter MJ, Tang L, Krajewska M, Reed JC, Ho VC, Li G 1998 p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes. Am J Pathol 153:579-585
300. Hansson HA, Jonsson R, Petruson K 1988 Transiently increased insulin-like growth factor. I. Immunoreactivity in UVB-irradiated mouse skin. J Invest Dermatol 91:328-332
301. Kuhn C, Hurwitz SA, Kumar MG, Cotton J, Spandau DF 1999 Activation of the insulin-like growth factor-1 receptor promotes the survival of human keratinocytes following ultraviolet B irradiation. Int J Cancer 80:431-438
302. DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S, Ramirez A, Jorcano J, Kiguchi K 2000 Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res 60:1561-1570
303. Shen S, Wertheimer E, Sampson SR, Tennenbaum T 2000 Characterization of glucose transport system in keratinocytes: insulin and IGF-1 differentially affect specific transporters. J Invest Dermatol 115:949-954
304. Pittelkow MR, Shipley GD 1989 Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements. J Cell Physiol 140:565-576
305. Nickoloff BJ 1999 The immunologic and genetic basis of psoriasis. Arch Dermatol 135:1104-1110
306. Weber G, Neidhardt M, Schmidt A, Geiger A 1981 Correlation of growth hormone and aetiology of psoriasis. Arch Dermatol Res 270:129-140
307. Weber G, Pliess G, Heitz U 1985 Growth hormone producing hyperplasia of pituitary gland in psoriasis. Arch Dermatol Res 277:345
308. Maghnie M, Borroni G, Larizza D, Lorini R, Girani MA, Rabbiosi G, Severi F 1990 Relapsing eruptive psoriasis and immunological changes triggered by growth hormone therapy in a growth hormone-deficient girl. Dermatologica 181:139-141
309. MacKie RM, Beastall GM, Thomson JA 1983 Growth hormone levels in psoriasis. Arch Dermatol Res 275:207
310. Priestley GC, Gawkrodger DJ, Seth J, Going SM, Hunter JA 1984 Growth hormone levels in psoriasis. Arch Dermatol Res 276:147-150
311. Nickoloff BJ, Misra P, Morhenn VB, Hintz RL, Rosenfeld RG 1987 Plasma somatomedin-C levels in psoriasis. Br J Dermatol 116:15-20
312. Bjorntorp E, Wickelgren R, Bjarnason R, Swanbeck G, Carlsson LM, Lindahl A 1997 No evidence for involvement of the growth hormone/insulin-like growth factor-1 axis in psoriasis. J Invest Dermatol 109:661-665
313. Guilhou JJ, Boulanger A, Barneon G, Vic P, Meynadier J, Tardieu JC, Clot J 1982 Somatostatin treatment of psoriasis. Arch Dermatol Res 274:249-257
314. Weber G, Klughardt G, Neidhardt M, Galle K, Frey H, Geiger A 1982 Treatment of psoriasis with somatostatin. Arch Dermatol Res 272:31-36
315. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H 1990 Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem Biophys Res Commun 168:396-401
316. Ristow HJ 1993 Effect of insulin-like growth factor-I/somatomedin C on thymidine incorporation in cultured psoriatic keratinocytes after growth arrest in growth factor-free medium. Growth Regul 3:129-137
317. Ristow HJ 1997 Increased synergistic effect of EGF and IGF-I on DNA synthesis of cultured psoriatic keratinocytes. Dermatology 195:213-219
318. Swygart C 1997 Human papillomavirus: disease and laboratory diagnosis. Br J Biomed Sci 54:299-303
319. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM 1989 Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099-4105
320. Lang PG 2002 Current concepts in the management of patients with melanoma. Am J Clin Dermatol 3:401-426
321. Bourguignon JP, Pierard GE, Ernould C, Heinrichs C, Craen M, Rochiccioli P, Arrese JE, Franchimont C 1993 Effects of human growth hormone therapy on melanocytic naevi. Lancet 341:1505-1506
322. Pierard GE, Pierard-Franchimont C, Nikkels A, Nikkels-Tassoudji N, Arrese JE, Bourguignon JP 1996 Naevocyte triggering by recombinant human growth hormone. J Pathol 180:74-79
323. Zvulunov A, Wyatt DT, Laud PW, Esterly NB 1997 Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol 137:545-548
324. Wyatt D 1999 Melanocytic nevi in children treated with growth hormone. Pediatrics 104:1045-1050
325. Corcuff JB, Ogor C, Kerlan V, Rougier MB, Bercovichi M, Roger P 1997 Ocular naevus and melanoma in acromegaly. Clin Endocrinol (Oxf) 47:119-121
326. Fleming MG, Howe SF, Graf Jr LH 1994 Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol 16:383-391
327. Hodak E, Gottlieb AB, Colen S, Anzilotti M, Krueger JG 1996 In vivo expression of the insulin-like growth factor-I (IGF-I) receptor in congenital pigmented nevi. J Cutan Pathol 23:19-24
328. Rodeck U, Herlyn M, Koprowski H 1987 Interactions between growth factor receptors and corresponding monoclonal antibodies in human tumors. J Cell Biochem 35:315-320
329. Herlyn M, Kath R, Williams N, Valyi-Nagy I, Rodeck U 1990 Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro. Adv Cancer Res 54:213-234
330. Graeven U, Herlyn M 1992 In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J Immunother 12:199-202
331. Graeven U, Rodeck U, Weinmann R, Herlyn M 1992 Stable transfection of human malignant melanoma cells with basic fibroblast growth factor antisense cDNA. Ann NY Acad Sci 660:293-294
332. Becker D, Lee PL, Rodeck U, Herlyn M 1992 Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7:2303-2313
333. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R 1994 Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54:4848-4850
334. Wang Y, Becker D 1997 Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 3:887-893
335. Werner H, Karnieli E, Rauscher FJ, LeRoith D 1996 Wild-type and mutant
336. Girnita L, Girnita A, Brodin B, Xie Y, Nilsson G, Dricu A, Lundeberg J, Wejde J, Bartolazzi A, Wiman KG, Larsson O 2000 Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact. Cancer Res 60:5278-5283
337. Harris CC 1996 p53: At the crossroads of molecular carcinogenesis and molecular epidemiology. J Investig Dermatol Symp Proc 1: 115-118
338. Stracke ML, Kohn EC, Aznavoorian SA, Wilson LL, Salomon D, Krutzsch HC, Liotta LA, Schiffmann E 1988 Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Commun 153:1076-1083
339. Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffmann E 1989 The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem 264:21544-21549
340. Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B, Herlyn M 1991 Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97:20-26
341. Olney RC, Anhalt H, Neely EK, Wilson DM 1995 A quantitative assay for IGF-I and IGF binding protein mRNAs: expression in malignant melanoma cells. Mol Cell Endocrinol 110:213-223
342. Ward A, Bates P, Fisher R, Richardson L, Graham CF 1994 Disproportionate growth in mice with IGF-2 transgenes. Proc Natl Acad Sci USA 91:10365-10369
343. Bol DK, Kiguchi K, Gimenez-Conti I, Rupp T, DiGiovanni J 1997 Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene 14:1725-1734
344. Eming SA, Snow RG, Yarmush ML, Morgan JR 1996 Targeted expression of insulin-like growth factor to human keratinocytes: modification of the autocrine control of keratinocyte proliferation. J Invest Dermatol 107:113-120
345. Rubini M, Hongo A, D'Ambrosio C, Baserga R 1997 The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp Cell Res 230:284-292
346. Wilker E, Bol D, Kiguchi K, Rupp T, Beltran L, DiGiovanni J 1999 Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice. Mol Carcinog 25:122-131
347. Harding KG, Morris HL, Patel GK 2002 Science, medicine and the future: healing chronic wounds. BMJ 324:160-163
348. Falabella AF, Falanga V 2001 Wound healing. In: Freinkel RK, Woodley DT, eds. The biology of the skin. 1st ed. Pearl River, NY: The Parthenon Publishing Group; 281-297
349. Rasmussen LH, Garbarsch C, Schuppan D, Moe D, Horslev-Pedersen K, Gottrup F, Steenfos H 1995 Dose response profiles of human growth hormone in subcutaneous wound chambers in rats. Eur J Surg 161:157-162
350. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN 1994 Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 220:19-24
351. Ghofrani A, Holler D, Schuhmann K, Saldern S, Messmer BJ 1999 The influence of systemic growth hormone administration on the healing time of skin graft donor sites in a pig model. Plast Reconstr Surg 104:470-475
352. Jorgensen PH, Andreassen TT 1987 A dose-response study of the effects of biosynthetic human growth hormone on formation and strength of granulation tissue. Endocrinology 121:1637-1641
353. Jorgensen PH, Andreassen TT 1988 The influence of biosynthetic human growth hormone on biomechanical properties and collagen formation in granulation tissue. Horm Metab Res 20:490-493
354. Jorgensen PH, Bang C, Andreassen TT, Flyvbjerg A, Orskov H 1995 Dose-response study of the effect of growth hormone on mechanical properties of skin graft wounds. J Surg Res 58:295-301
355. Seyer-Hansen M, Andreassen TT, Oxlund H 1999 Strength of colonic anastomoses and skin incisional wounds in old rats -influence by diabetes and growth hormone. Growth Horm IGF Res 9:254-261
356. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL 1990 Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 212:424-429
357. Moller S, Jensen M, Svensson P, Skakkebaek NE 1991 Insulin-like growth factor 1 (IGF-1) in burn patients. Burns 17:279-281
358. Singh KP, Prasad R, Chari PS, Dash RJ 1998 Effect of growth hormone therapy in burn patients on conservative treatment. Burns 24:733-738
359. Jeschke MG, Chrysopoulo MT, Herndon DN, Wolf SE 1999 Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res 85:171-177
360. Meyer NA, Barrow RE, Herndon DN 1996 Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats. J Trauma 41:1008-1012
361. Pierre EJ, Perez-Polo JR, Mitchell AT, Matin S, Foyt HL, Herndon DN 1997 Insulin-like growth factor-I liposomal gene transfer and systemic growth hormone stimulate wound healing. J Burn Care Rehabil 18:287-291
362. Vogt PM, Lehnhardt M, Wagner D, Jansen V, Krieg M, Steinau HU 1998 Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion. Plast Reconstr Surg 102:117-123
363. Hathaway CL, Arnold AM, Rand RP, Engrav LH, Quinn LS 1996 Differential expression of IGFBPs by normal and hypertrophic scar fibroblasts. J Surg Res 60:156-162
364. Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, Harmon JW 1995 Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 59:236-244
365. Roesel JF, Nanney LB 1995 Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J Surg Res 58:449-459
366. Ghahary A, Tredget EE, Shen Q 1999 Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-β1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system. J Cell Physiol 180:61-70
367. Bitar MS, Pilcher CW, Khan I, Waldbillig RJ 1997 Diabetes-induced suppression of IGF-1 and its receptor mRNA levels in rat superior cervical ganglia. Diabetes Res Clin Pract 38:73-80
368. Suh DY, Hunt TK, Spencer EM 1992 Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 131:2399-2403
369. Ghahary A, Fu S, Shen YJ, Shankowsky HA, Tredget EE 1994 Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Mol Cell Biochem 135:171-180
370. Bastian SE, Walton PE, Belford DA 2000 Transport of circulating IGF-I and LR3IGF-I from blood to extracellular wound fluid sites in rats. J Endocrinol 164:77-86
371. Robertson JG, Pickering KJ, Belford DA 1996 Insulin-like growth factor I (IGF-I) and IGF-binding proteins in rat wound fluid. Endocrinology 137:2774-2781
372. Lemmey AB, Glassford J, Flick-Smith HC, Holly JM, Pell JM 1997 Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol 154:319-328
373. Hamon GA, Hunt TK, Spencer EM 1993 In vivo effects of systemic insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul 3:53-56
374. Jyung RW, Mustoe JA, Busby WH, Clemmons DR 1994 Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery 115:233-239
375. Lee YR, Oshita Y, Tsuboi R, Ogawa H 1996 Combination of insulin-like growth factor (IGF)-I and IGF-binding protein-1 promotes fibroblast-embedded collagen gel contraction. Endocrinology 137:5278-5283
376. Galiano RD, Zhao LL, Clemmons DR, Roth SI, Lin X, Mustoe TA 1996 Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model. J Clin Invest 98:2462-2468
377. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR 1991 Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481-7485
378. Jeschke MG, Barrow RE, Hawkins HK, Chrysopoulo MT, Perez-Polo JR, Herndon DN 1999 Effect of multiple gene transfers of insulin-like growth factor I complementary DNA gene constructs in rats after thermal injury. Arch Surg 134:1137-1141
379. Jeschke MG, Barrow RE, Hawkins HK, Tao Z, Perez-Polo JR, Herndon DN 2000 Biodistribution and feasibility of non-viral IGF-I gene transfers in thermally injured skin. Lab Invest 80:151-158
380. Jeschke MG, Richter G, Herndon DN, Geissler EK, Hartl M, Hofstatter F, Jauch KW, Perez-Polo JR 2001 Therapeutic success and efficacy of nonviral liposomal cDNA gene transfer to the skin in vivo is dose dependent. Gene Ther 8:1777-1784
381. Spies M, Nesic O, Barrow RE, Perez-Polo JR, Herndon DN 2001 Liposomal IGF-1 gene transfer modulates pro-and anti-inflammatory cytokine mRNA expression in the burn wound. Gene Ther 8:1409-1415
382. Vogt PM, Thompson S, Andree C, Liu P, Breuing K, Hatzis D, Brown H, Mulligan RC, Eriksson E 1994 Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci USA 91:9307-9311
383. De Luca M, Pellegrini G 1997 The importance of epidermal stem cells in keratinocyte-mediated gene therapy. Gene Ther 4:381-383
384. Dews M, Prisco M, Peruzzi F, Romano G, Morrione A, Baserga R 2000 Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases. Endocrinology 141:1289-1300
385. Butt AJ, Williams AC 2001 IGFBP-3 and apoptosis-a license to kill? Apoptosis 6:199-205
386. Amagai M, Ozawa S, Ueda M, Nishikawa T, Abe O, Shimizu N 1988 Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease. Br J Dermatol 119:661-668
387. Gottlieb AB, Khandke L, Krane JF, Staiano-Coico L, Ashinoff R, Krueger JG 1992 Anthralin decreases keratinocyte TGF-α expression and EGF-receptor binding in vitro. J Invest Dermatol 98:680-685
388. Watts P, Stables GS, Akhurst RJ, Mackie RM 1994 Localization of transforming growth factor-α RNA and protein in the skin of psoriatic patients receiving therapy. Br J Dermatol 131:64-71
389. Sergi C, Kahl P, Otto HF 2000 Immunohistochemical localization of transforming growth factor-α and epithelial growth factor receptor in human fetal developing skin, psoriasis and restrictive dermopathy. Pathol Oncol Res 6:250-255
390. Sakai Y, Nelson KG, Snedeker S, Bossert NL, Walker MP, McLachlan J, DiAugustine RP 1994 Expression of epidermal growth factor in suprabasal cells of stratified squamous epithelia: implications for a role in differentiation. Cell Growth Differ 5:527-535
391. Breitkreutz D, Stark HJ, Plein P, Baur M, Fusenig NE 1993 Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+. Differentiation 54:201-217
392. Denning MF, Guy SG, Ellerbroek SM, Norvell SM, Kowalczyk AP, Green KJ 1998 The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. Exp Cell Res 239:50-59
393. Watt FM, Hogan BL 2000 Out of Eden: stem cells and their niches. Science 287:1427-1430